Skip to main content
Premium Trial:

Request an Annual Quote

French Crop Science Firm Biogemma Says Oui to LION

NEW YORK, Sept. 19-Lion Bioscience licensed its bioinformatics platform to both the French crop science company Biogemma and its joint venture with Bayer Crop Science, the company said today.

The companies will  use Lion's technology in plant disease research.


RhoBio, the joint venture, will use Lion's SRS system to integrate disease-related genetic data.


Biogemma will use Lion's BioScout application to analyze plant gene sequences.


These are the bioinformatics company's first French crop science clients.


RhoBio, a joint venture begun in April 1998, focuses on Arabidopsis genomics and its applications to crops like maize, wheat, rice and oilseed rape.


Biogemma is based in Paris.


For more information, see Lion's press release.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.